Clinic
Century Medical & Dental Center INC
Century Medical & Dental Center INC was paid $38.63M by Medicaid between Jan 2018 and Dec 2024, across 315 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoCENTURY MEDICAL & DENTAL CENTER INC
BROOKLYN, NY 11223
BROOKLYN, NY 11223
33aNPI1144399098assigned 11/07/2006
33bProvider typeHealth Service Clinic/Center
28Total paid$38.63M
24GClaims868,176
24DCodes billed315
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Service Clinic/Center providers in New York
Rank by total paid#2 of 54
Median peer was paid$410K
This provider vs. median94×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,231 | $700K | |
| 2019 | 56,352 | $2.24M | |
| 2020 | 99,301 | $5.06M | |
| 2021 | 134,235 | $5.18M | |
| 2022 | 182,455 | $8.02M | |
| 2023 | 201,403 | $10.09M | |
| 2024incomplete | 176,199 | $7.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 116,822 | 84,004 | $9.95M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 5.5% | 18,664 | 7,718 | $2.14M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.0% | 32,502 | 8,710 | $1.95M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.8% | 23,104 | 12,676 | $1.85M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.0% | 14,742 | 13,292 | $1.56M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 3.8% | 3,609 | 3,532 | $1.47M |
| 93976 | 3.6% | 6,580 | 6,283 | $1.39M | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 3.0% | 2,668 | 2,607 | $1.16M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.8% | 7,129 | 5,801 | $692K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.5% | 28,222 | 7,975 | $561K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 2,452 | 2,384 | $537K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.3% | 6,380 | 2,462 | $514K |
303 more codes
| 93886 | 1.2% | 1,231 | $473K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 1.2% | 7,283 | $470K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.2% | 841 | $456K |
| 97124 | 1.1% | 24,808 | $439K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 1.0% | 6,408 | $393K |
| 99000 | <1% | 21,289 | $356K | |
| 90837 | Psychotherapy session, about an hour | <1% | 3,359 | $355K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 3,050 | $346K |
| 99443 | <1% | 3,090 | $346K | |
| 99385 | <1% | 3,061 | $319K | |
| 93892 | <1% | 1,226 | $314K | |
| 76770 | <1% | 997 | $300K | |
| 93925 | <1% | 600 | $236K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 8,777 | $229K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 8,766 | $221K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 8,724 | $215K |
| 93970 | <1% | 466 | $208K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 2,024 | $201K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,052 | $199K |
| 81514 | <1% | 1,024 | $192K | |
| 97161 | <1% | 2,187 | $190K | |
| 76830 | Ultrasound, transvaginal | <1% | 2,676 | $190K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 15,567 | $189K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,230 | $186K |
| 99441 | <1% | 1,711 | $181K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 6,886 | $175K |
| D1110 | Prophylaxis - adult | <1% | 4,457 | $174K |
| 31231 | <1% | 1,135 | $158K | |
| 99401 | <1% | 4,751 | $156K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,526 | $154K |
| D0120 | Dental checkup, returning patient | <1% | 6,297 | $152K |
| 93880 | <1% | 428 | $146K | |
| 17360 | <1% | 683 | $132K | |
| 76536 | <1% | 1,582 | $131K | |
| 95117 | <1% | 6,793 | $129K | |
| 97014 | <1% | 7,382 | $125K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 26,699 | $125K |
| 92015 | Determination of refractive state | <1% | 2,557 | $120K |
| 93890 | <1% | 1,058 | $119K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 3,885 | $118K |
| 80061 | Lipid panel | <1% | 13,648 | $118K |
| 99442 | <1% | 996 | $113K | |
| 10040 | <1% | 751 | $112K | |
| 97010 | <1% | 8,180 | $108K | |
| 99051 | <1% | 9,946 | $107K | |
| 80050 | General health panel | <1% | 3,017 | $104K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,359 | $101K |
| 82607 | <1% | 9,020 | $101K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 1,770 | $101K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,445 | $100K |
| 90836 | <1% | 1,331 | $99K | |
| 80053 | Comprehensive metabolic panel | <1% | 11,533 | $96K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 4,546 | $93K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 3,372 | $92K |
| 99386 | <1% | 815 | $91K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,176 | $90K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 3,180 | $88K |
| 11102 | <1% | 197 | $86K | |
| 97162 | <1% | 807 | $85K | |
| 11056 | <1% | 895 | $84K | |
| 11721 | <1% | 2,456 | $83K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,279 | $79K |
| 86480 | <1% | 1,574 | $78K | |
| 97032 | <1% | 3,734 | $77K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 698 | $74K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,389 | $69K |
| 80074 | <1% | 2,003 | $68K | |
| 95024 | <1% | 171 | $68K | |
| 84481 | <1% | 5,611 | $65K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,590 | $65K |
| 93882 | <1% | 882 | $65K | |
| 92557 | <1% | 1,302 | $63K | |
| 84439 | <1% | 9,132 | $63K | |
| 76775 | <1% | 1,018 | $60K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,638 | $59K |
| 11901 | <1% | 323 | $58K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,103 | $57K |
| 97116 | <1% | 1,550 | $57K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,228 | $56K |
| 88142 | <1% | 3,127 | $54K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 250 | $52K |
| 82746 | <1% | 4,631 | $51K | |
| 86706 | <1% | 5,948 | $49K | |
| 92546 | <1% | 573 | $45K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,288 | $44K |
| 86703 | <1% | 3,743 | $43K | |
| 95886 | <1% | 403 | $42K | |
| 92540 | <1% | 575 | $42K | |
| 86696 | <1% | 2,680 | $39K | |
| 87390 | <1% | 2,028 | $39K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 2,271 | $39K |
| 92567 | <1% | 672 | $35K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 981 | $35K |
| 86803 | <1% | 3,420 | $34K | |
| 92202 | <1% | 513 | $34K | |
| 93000 | <1% | 4,841 | $34K | |
| 92550 | <1% | 753 | $34K | |
| 92537 | <1% | 578 | $34K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 3,268 | $33K |
| 87150 | <1% | 172 | $32K | |
| 84480 | <1% | 4,317 | $31K | |
| 82728 | <1% | 2,769 | $31K | |
| 31575 | <1% | 304 | $31K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,231 | $30K |
| 87481 | <1% | 639 | $29K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 335 | $29K |
| 86780 | <1% | 2,656 | $29K | |
| 87340 | <1% | 3,532 | $28K | |
| 84403 | <1% | 1,297 | $27K | |
| 81001 | <1% | 10,239 | $27K | |
| 36416 | <1% | 1,445 | $27K | |
| 94060 | <1% | 136 | $26K | |
| 98928 | <1% | 1,943 | $25K | |
| 86708 | <1% | 2,738 | $25K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 947 | $25K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 396 | $25K |
| 86704 | <1% | 2,767 | $24K | |
| 92547 | <1% | 505 | $24K | |
| D2750 | <1% | 66 | $23K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 509 | $23K |
| 86695 | <1% | 2,536 | $23K | |
| 86702 | <1% | 2,120 | $22K | |
| 82670 | <1% | 997 | $22K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,051 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,963 | $22K |
| 92588 | <1% | 479 | $21K | |
| 11900 | <1% | 149 | $21K | |
| A4614 | Peak expiratory flow rate meter, hand held | <1% | 1,040 | $19K |
| 84153 | <1% | 1,295 | $19K | |
| H0001 | Alcohol and/or drug assessment | <1% | 153 | $19K |
| D0330 | Panoramic radiographic image | <1% | 672 | $19K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 493 | $18K |
| 92083 | <1% | 293 | $18K | |
| 82627 | <1% | 994 | $18K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 113 | $17K |
| 83002 | <1% | 1,106 | $16K | |
| 83001 | <1% | 1,097 | $16K | |
| 84146 | <1% | 1,058 | $16K | |
| 84144 | <1% | 957 | $16K | |
| 92133 | <1% | 253 | $16K | |
| 86701 | <1% | 2,094 | $15K | |
| 84154 | <1% | 985 | $15K | |
| 87500 | <1% | 202 | $15K | |
| 86592 | <1% | 4,242 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,125 | $14K |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 192 | $13K |
| 84436 | <1% | 3,803 | $13K | |
| 86762 | <1% | 1,098 | $13K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,636 | $13K |
| 84425 | <1% | 879 | $13K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 339 | $12K |
| 86765 | <1% | 1,147 | $11K | |
| 99406 | <1% | 335 | $11K | |
| 98927 | <1% | 1,176 | $10K | |
| 83540 | <1% | 2,326 | $10K | |
| 86735 | <1% | 1,085 | $10K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 462 | $10K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 461 | $10K |
| 86787 | <1% | 1,082 | $10K | |
| D0274 | Bitewings - four radiographic images | <1% | 520 | $10K |
| 94010 | <1% | 193 | $9K | |
| 92201 | <1% | 129 | $9K | |
| 86769 | <1% | 426 | $9K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 180 | $9K |
| V2020 | Frames, purchases | <1% | 187 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 479 | $8K |
| 84270 | <1% | 563 | $8K | |
| 95813 | <1% | 25 | $8K | |
| 82180 | <1% | 961 | $8K | |
| 84702 | <1% | 677 | $8K | |
| 83550 | <1% | 1,423 | $8K | |
| 92587 | <1% | 288 | $8K | |
| 90688 | <1% | 404 | $7K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 208 | $7K |
| 82248 | <1% | 1,526 | $7K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 134 | $7K |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 342 | $7K |
| 17110 | <1% | 37 | $7K | |
| 81002 | <1% | 5,166 | $6K | |
| 64566 | <1% | 1,296 | $6K | |
| 87350 | <1% | 632 | $6K | |
| 86707 | <1% | 610 | $5K | |
| 87640 | <1% | 218 | $5K | |
| 87653 | <1% | 218 | $5K | |
| 82043 | <1% | 1,153 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 220 | $5K |
| 97035 | <1% | 219 | $5K | |
| 95816 | <1% | 25 | $5K | |
| 84252 | <1% | 642 | $5K | |
| 84207 | <1% | 191 | $4K | |
| 81025 | <1% | 1,441 | $4K | |
| 95910 | <1% | 28 | $4K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 48 | $4K |
| 84466 | <1% | 335 | $3K | |
| D9110 | <1% | 176 | $3K | |
| 95819 | <1% | 14 | $3K | |
| 11055 | <1% | 215 | $3K | |
| 90746 | <1% | 100 | $3K | |
| 83735 | <1% | 572 | $3K | |
| 90756 | <1% | 127 | $3K | |
| 86376 | <1% | 230 | $3K | |
| 82570 | <1% | 876 | $3K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 63 | $3K |
| 99490 | Ccm add 20min | <1% | 507 | $3K |
| 86800 | <1% | 202 | $3K | |
| 3078F | <1% | 8,277 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 16 | $2K |
| 87088 | <1% | 291 | $2K | |
| 86038 | <1% | 254 | $2K | |
| 76857 | <1% | 147 | $2K | |
| 87641 | <1% | 79 | $2K | |
| 86328 | <1% | 72 | $2K | |
| 92002 | <1% | 15 | $2K | |
| 81015 | <1% | 716 | $1K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 48 | $1K |
| 86235 | <1% | 17 | $1K | |
| 98925 | <1% | 63 | $1K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 94 | $1K |
| 84311 | <1% | 218 | $1K | |
| 86317 | <1% | 43 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 162 | $1K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 14,250 | $971.90 |
| 85651 | <1% | 290 | $894.72 | |
| 2010F | <1% | 22,526 | $890.09 | |
| 3074F | <1% | 8,382 | $852.51 | |
| 87660 | <1% | 58 | $824.25 | |
| 97802 | <1% | 31 | $806.22 | |
| 80353 | <1% | 163 | $764.50 | |
| 82962 | <1% | 1,388 | $746.91 | |
| 87510 | <1% | 58 | $726.60 | |
| 87480 | <1% | 58 | $726.60 | |
| 81000 | <1% | 97 | $718.04 | |
| 84550 | <1% | 151 | $676.12 | |
| 86413 | <1% | 37 | $674.02 | |
| 82947 | <1% | 1,050 | $662.38 | |
| 80320 | <1% | 133 | $654.00 | |
| D0140 | Limited oral evaluation - problem focused | <1% | 64 | $650.49 |
| 80351 | <1% | 129 | $609.50 | |
| 80171 | <1% | 58 | $609.00 | |
| 86003 | <1% | 14 | $591.29 | |
| 83986 | <1% | 218 | $525.89 | |
| 90674 | <1% | 14 | $513.08 | |
| 80359 | <1% | 99 | $484.50 | |
| 84402 | <1% | 24 | $453.59 | |
| 84479 | <1% | 142 | $443.45 | |
| 99050 | <1% | 64 | $427.94 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 34 | $426.30 |
| 90658 | <1% | 38 | $400.15 | |
| 87186 | <1% | 61 | $396.46 | |
| 90715 | <1% | 12 | $395.90 | |
| 85045 | <1% | 119 | $366.79 | |
| 86431 | <1% | 79 | $359.05 | |
| 85610 | <1% | 113 | $334.54 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 35 | $328.99 |
| 84315 | <1% | 127 | $296.06 | |
| 86225 | <1% | 29 | $283.47 | |
| 86705 | <1% | 32 | $258.97 | |
| 3008F | <1% | 18,389 | $245.00 | |
| 81003 | <1% | 269 | $244.53 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 579 | $239.77 |
| 80324 | <1% | 42 | $210.00 | |
| 80358 | <1% | 40 | $200.00 | |
| 80347 | <1% | 39 | $195.00 | |
| 80345 | <1% | 38 | $185.00 | |
| 81005 | <1% | 115 | $181.11 | |
| 85730 | <1% | 37 | $180.67 | |
| 86304 | <1% | 12 | $174.20 | |
| 86140 | <1% | 39 | $165.15 | |
| 80361 | <1% | 24 | $120.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | $115.70 |
| 80363 | <1% | 23 | $115.00 | |
| 80349 | <1% | 22 | $110.00 | |
| 87070 | <1% | 15 | $106.31 | |
| 99072 | <1% | 6,997 | $101.05 | |
| 94760 | <1% | 47 | $100.74 | |
| 69210 | <1% | 12 | $70.75 | |
| 83519 | <1% | 88 | $69.54 | |
| 80335 | <1% | 24 | $60.00 | |
| 83014 | <1% | 14 | $55.82 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 444 | $52.54 |
| 82977 | <1% | 13 | $30.45 | |
| 80362 | <1% | 24 | $5.00 | |
| 1159F | <1% | 1,992 | $3.54 | |
| 1160F | <1% | 1,518 | $3.53 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 110 | $0.09 |
| 3079F | 0% | 998 | $0.00 | |
| 1125F | 0% | 402 | $0.00 | |
| 1126F | 0% | 521 | $0.00 | |
| 3061F | 0% | 32 | $0.00 | |
| 3075F | 0% | 671 | $0.00 | |
| 3080F | 0% | 182 | $0.00 | |
| 3044F | 0% | 143 | $0.00 | |
| 3048F | 0% | 12 | $0.00 | |
| 3049F | 0% | 13 | $0.00 | |
| 1100F | 0% | 13 | $0.00 | |
| 1116F | 0% | 254 | $0.00 | |
| 80346 | 0% | 16 | $0.00 | |
| 3077F | 0% | 492 | $0.00 | |
| 99499 | 0% | 368 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 27 | $0.00 |
| 4013F | 0% | 13 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 27 | $0.00 |
| 3046F | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZUSMAN, VALENTIN (ADMINISTRATOR)